Ignite Creation Date:
2024-05-06 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 12:43 PM
Study NCT ID:
NCT03492632
Status:
COMPLETED
Last Update Posted:
2018-07-06
First Post:
2018-04-03
Brief Title:
Ovarian Reserve in Patients With Psoriasis
Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Organization:
Kanuni Sultan Suleyman Training and Research Hospital
Study Overview
Official Title:
Ovarian Reserve in Patients With Psoriasis
Status:
COMPLETED
Status Verified Date:
2018-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Psoriasis is a common autoimmune disease It affects women of all ages including reproductive years Autoimmune diseases including psoriasis are linked to premature ovarian reserve This study aims to measure serum hormones including FSHLHE2PRL and AMH indicators of ovarian reserve in women with and without psoriasis
Detailed Description:
Psoriasis is a common autoimmune disease It affects women of all ages including reproductive years Almost 75 of patients are diagnosed before the age of 40 There is also increased evidence on autoimmune disease and their link to premature ovarian failureOvarian reserve is important for the reproductive period The measurements of serum hormones including follicle stimulating hormone FSHluteinizing hormone LHprolactin PRL estradiol E2 and anti-mullerian hormone AMH will give us an idea about the ovarian reserve The investigators aim is to measure ovarian reserve parameters in patients newly diagnosed with psoriasis and to compare them to healthy controls Serum FSHLHE2PRL and AMH will be measured on the 3rd day of the cycleThe serum hormone levels will be compared between women with psoriasis and women without psoriasis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None